A gene expression study by Iglesia et al. [111] that focused on B cells indicated that the improved prognosis (metastasis-free survival) correlates well with B-cell gene expression, particularly in basal-like and HER2-enriched breast cancer subtypes. This evidence concerns the gene ERBB2 and breast carcinoma.